Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
379
-
Total 13F shares, excl. options
-
162,459,664
-
Shares change
-
+1,228,483
-
Total reported value, excl. options
-
$13,396,780,263
-
Value change
-
+$49,991,390
-
Put/Call ratio
-
78.45%
-
Number of buys
-
203
-
Number of sells
-
-170
-
Price
-
$82.48
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q1 2016
471 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q1 2016.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 379 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 162,459,664 shares
of 193,539,047 outstanding shares and own 83.94% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (15,853,295 shares), FMR LLC (13,459,463 shares), SANDS CAPITAL MANAGEMENT, LLC (11,561,504 shares), VANGUARD GROUP INC (11,102,321 shares), JENNISON ASSOCIATES LLC (8,749,891 shares), PRIMECAP MANAGEMENT CO/CA/ (7,350,369 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,218,760 shares), BAKER BROS. ADVISORS LP (4,806,483 shares), JPMORGAN CHASE & CO (4,486,438 shares), and BlackRock Institutional Trust Company, N.A. (3,809,516 shares).
This table shows the top 379 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.